Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use: Guidance for Industry and Food and Drug Administration Staff
Information
Type
Guidance
Regulated products
Medical Devices
Topics
Premarket
Published
September 29, 2020
Last updated
January 26, 2021
Description
A guidance document by the FDA for the premarket use of blood glucose monitoring test systems in prescription point-of-care settings.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)